 |
|
|
Vol. 127 No. 12, December 1992 |
 |
|
|
|
|
|
|
|
|
|
PAPERS PRESENTED AT THE 45TH ANNUAL CANCER SYMPOSIUM OF THE SOCIETY OF SURGICAL ONCOLOGY, NEW YORK, NY, MARCH 15-18, 1992 |
|
|
|
Immunotherapy With a Tumor-Infiltrating Lymphocyte Clone, Soluble Antigen, and Cyclophosphamide
Hirotaka Komichi, MD, PhD;
Scott Smith;
Barry D. Kahan, MD, PhD
Arch Surg. 1992;127(12):1417-1423.
Abstract
• A tumor-specific cytotoxic T-lymphocyte clone derived from bulk cultures of tumor-infiltrating lymphocytes attenuated the outgrowth of methylcholanthrene (MCA)—induced fibrosarcomas in C3H/HeJ mice. In 4-hour chromium 51–release assays, bulk cultures of tumor-infiltrating lymphocytes showed nonspecificity for MCA-induced tumors (MCA-F, MCA-D, MCA-SP), YAC-1, and EL-4. In contrast, a cytotoxic T-lymphocyte—cloned line specifically killed MCA-F, but not MCA-D or MCA-SP. Cytotoxic T-lymphocyte line 8 protected syngeneic hosts in local and systemic adoptive transfer assays. Hosts bearing 4-day-established MCA-F tumor cells received single agents or combinations of isoelectrophoretically purified butyl alcohol—extracted tumor-specific transplantation antigen (1 µg/wk), cyclophosphamide (20 mg/kg on days 4 and 11), and/or cytotoxic T-lymphocytes (1 x 107 cells on days 7 and 14). While the mean tumor diameter was 11.6±1.3 mm in untreated hosts or after single treatments, the combination of tumor-specific transplantation antigen and cyclophosphamide along with the cytotoxic T-lymphocyte clone resulted in tumor diameters of 1.8±0.5 mm. The triple combination prolonged host survival from 39.6±1.6 to 57.2±4.7 days compared with antigen and cyclophosphamide treatment.
(Arch Surg. 1992;127:1417-1423)
Author Affiliations
From the Division of Immunology and Organ Transplantation, Department of Surgery, The University of Texas Medical School at Houston.
Footnotes
Accepted for publication July 25, 1992.
Presented at the 45th Annual Cancer Symposium of the Society of Surgical Oncology, New York, NY, March 16, 1992.
Reprint requests to Division of Immunology and Organ Transplantation, Department of Surgery, University of Texas Medical School, Texas Medical Center, 6431 Fannin, Suite 6240, Houston, TX 77030 (Dr Kahan).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
|
|
|
